Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)-Reference-Cited by-同舟云学术

Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)

Published:2018-11 Issue:9 Volume:6 Page:1380-1390
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Sturm Lukas¹,Bettinger Dominik¹²^ORCID,Giesler Max¹,Boettler Tobias¹,Schmidt Arthur¹,Buettner Nico¹,Thimme Robert¹,Schultheiss Michael¹

Affiliation:

1. Department of Medicine IIMedical Center University of FreiburgFaculty of MedicineUniversity of FreiburgFreiburgGermany

2. Berta-Ottenstein-ProgrammeFaculty of MedicineUniversity of FreiburgFreiburgGermany

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640618795928

Reference30 articles.

1. Liver cirrhosis

2. Liver cirrhosis

3. TIPS: 25years later

4. Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS)

5. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Notfallmedizinisch relevante Komplikationen der Leberzirrhose;Notfallmedizin up2date;2024-06-25

2. Komplikationen der Leberzirrhose;Allgemein- und Viszeralchirurgie up2date;2024-05

3. High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study;Alimentary Pharmacology & Therapeutics;2024-02-22

4. Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy—A Review of the Past Decade’s Literature Focusing on Incidence, Risk Factors, and Prophylaxis;Journal of Clinical Medicine;2023-12-19

5. Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension;mBio;2023-10-31